4.7 Article

Functional mesoporous silica nanoparticles for delivering nimesulide with chiral recognition performance

期刊

出版社

ELSEVIER
DOI: 10.1016/j.micromeso.2019.109862

关键词

Functional mesoporous silica nanoparticles; Chiral recognition performance; Nimesulide; Oral bioavailability; Chiral medium

资金

  1. National Natural Science Foundation of China [81773672, 81903550]
  2. China Postdoctoral Science Foundation [2018M641755]

向作者/读者索取更多资源

It is predictable that carriers presented with chiral structure can display different drug delivery effect, which is of great interest and novelty in material science and pharmacy. Herein, we synthesized functional mesoporous silica nanoparticles (F-MSNs) with molecular level chiral function property. The obtained levorotatory MSNs and dextrorotatory MSNs were named as FL-MSNs and FD-MSNs, respectively. To explore their special features in delivering drug molecules, drug delivery systems based on FL-MSNs and FD-MSNs were established by using nimesulide (NMS) as model drug. Characterization techniques, including Fourier Transform infrared spectrometer (FTIR), circular dichroism (CD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), nitrogen adsorption/desorption measurement, were applied. The results showed that after loading NMS into FL-MSNs and FD-MSNs, most crystalline NMS converted to amorphous phase confirmed by differential scanning calorimeter (DSC) and X-ray power diffraction (XRD) analysis. Besides, FL-MSNs and FD-MSNs showed responses in corresponding chiral medium and FD-MSNs turned out to be the superior carrier. The superior chiral response performance of FD-MSNs was also confirmed using molecular simulation and wettability study. Finally, in vivo pharmacokinetics and anti-inflammatory pharmacodynamics studies indicated that both FL-MSNs and FDMSNs could improve the oral bioavailability of NMS (698.45% and 887.03% respectively), and FD-MSNs delivered more NMS after making response to the in vivo environment and thereafter presented stronger anti-inflammatory pharmacodynamics performance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据